## RJF: Raymond James Financial, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.23 indicates fundamental undervaluation. Quality metrics strong (ROE 18%). Caution: declining volume (49% of avg), momentum weakening (-2.2% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($156.78)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Raymond James (RJF): Buy, Sell, or Hold Post Q3 Earnings?**
- Source: TradingView â€” Track All Markets | 20251229T040824 | Bullish | Relevance: 100%
- Raymond James (RJF) shares have returned 7.8% over the last six months, trading at $165.32. The company, founded in 1962, exhibits strong fundamentals, including a 12% compounded annual revenue growth rate and a 21.2% compounded annual EPS growth rate over the past five years. Its Tangible Book Value per Share (TBVPS) has also increased significantly, reflecting a robust asset base.

**2. Raymond James (RJF): Buy, Sell, or Hold Post Q3 Earnings?**
- Source: Finviz | 20251228T110400 | Bullish | Relevance: 100%
- Raymond James Financial (RJF) has demonstrated strong financial performance with robust long-term revenue growth, outstanding EPS growth, and an increasing tangible book value per share. The article suggests that while these indicators are bullish, investors should conduct further research to determine if the current stock price of $165.32 presents a good entry point. The company's diversified financial services offerings and consistent growth metrics position it as a compelling investment.

**3. Empowering Business Owners Through ESOPs: A Raymond James Financial Advisor's Perspective**
- Source: Modern Luxury | 20251230T155833 | Bullish | Relevance: 100%
- This article discusses how Employee Stock Ownership Plans (ESOPs) provide a unique exit strategy for business owners. Raymond James Financial Advisors explain the benefits of ESOPs, including tax advantages, liquidity for owners, and employee empowerment through shared ownership. The process, considerations, and expertise offered by Raymond James are also highlighted for businesses seeking this type of transition.

**4. New Data From Raymond James Shows Business Owners Prioritize Unlocking Concentrated Wealth to Pursue New Ventures**
- Source: Yahoo Finance Singapore | 20251230T120700 | Bullish | Relevance: 100%
- A new Raymond James survey reveals that 88% of privately held business owners plan to partially or fully exit their businesses within the next decade, often not for retirement but to reinvest or acquire new ventures. Many owners have significant personal wealth tied to their companies, highlighting the need for comprehensive wealth planning. The study also indicates a strong preference for passing businesses to family members or internal stakeholders and identifies growth capital needs, with a potential gap in prioritizing human capital development for future success.

**5. Interactive Brokers vs. RJF: Which Brokerage Has the Edge Today?**
- Source: The Globe and Mail | 20251229T172538 | Somewhat-Bullish | Relevance: 100%
- This article compares two prominent brokerage firms, Interactive Brokers (IBKR) and Raymond James Financial (RJF), highlighting their different operating models and growth strategies. Interactive Brokers is lauded for its technology-driven, low-cost access to global markets, appealing to active and institutional traders. Raymond James, contrastingly, focuses on advisor-led wealth management services and diversified revenue streams, showcasing a more traditional approach.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $187 | $185 | +1% |
| 2025-12-10 | B of A Securiti | $196 | $194 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Equal-Weight |
| 2025-12-10 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 31 ($0.00M) |
| Sells | 18 ($0.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.1% (-1.4%)
- Blackrock Inc.: 7.4% (-2.9%)
- JPMORGAN CHASE & CO: 5.9% (+108.2%)
- Primecap Management : 4.9% (-3.7%)
- Wellington Managemen: 4.6% (-5.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.23 suggests fair value with growth premium. Forward P/E 12.1x attractive for 12% earnings growth. Quality metrics strong (margin 15%). Institutional flow bullish (1 buying vs 9 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.4B |
| Beta | 1.01 |
| 52W Range | $117.57 - $177.66 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.23 |
| Forward P/E | 12.1 |
| Current P/E | 13.6 |
| YoY Growth | 12.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.7% to -0.5% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.5pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.04x) but short-term weakness (below SMA20). RSI neutral at 50. Volume at 49% of 20MA suggests lack of conviction. OFD pattern: -F0L (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.48% (CS: 38) | Neutral |
| RSI_14 | 50.4 | Neutral |
| MACD Histogram | 0.05 | Bullish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 1.010x | Above |
| vs SMA200 | 1.041x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $162.56
- **Stop Loss:** $156.78 (3.6% risk)
- **Target:** $174.12 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 142
- **Position Value:** $23,083.52
- **Portfolio %:** 23.08%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-28 (Est: $2.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.11 | +10.0% |
| 2025Q2 | $2.36 | $2.18 | -7.5% |
| 2025Q1 | $2.44 | $2.42 | -0.7% |
| 2024Q4 | $2.69 | $2.93 | +8.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*